Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of April 30th, 2024
10 Mai 2024 - 5:45PM
Business Wire
Pursuant to article L-223-8 II of the French
“code de Commerce” and 223-16 of the AMF’s General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares
18,418,233
Number of real voting rights*
(excluding treasury shares**)
18,346,685
Theoretical number of voting
rights* (including treasury shares**)
18,298,337
(*) Class E preference shares are non-voting (**) pursuant to
article 223-11 of the AMF’s General Regulations
About Median Technologies: Pioneering in innovative imaging
solutions and services, Median Technologies harnesses cutting-edge
AI to elevate the accuracy of early cancer diagnoses and cancer
treatments. Median's offerings, including iCRO for medical image
analysis and management in oncology trials and eyonis™, AI/ML
tech-based suite of software as medical devices (SaMD), empower
biopharmaceutical entities and clinicians to advance patient care
and expedite novel therapies. The French-based company, with a
presence in the U.S. and China, is listed on the Euronext Growth
market (ISIN: FR0011049824, ticker: ALMDT). Median is eligible for
the French SME equity savings plan scheme (PEA-PME). For more
information: www.mediantechnologies.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240510877847/en/
Median Technologies Emmanuelle Leygues Head of Corporate
Marketing & Financial Communications +33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com
Press - ALIZE RP Caroline Carmagnol +33 6 64 18 99 59
median@alizerp.com
Investors - ACTIFIN Ghislaine Gasparetto +33 6 21 10 49
24 ghislaine.gasparetto@seitosei-actifin.com
Median Technologies (EU:ALMDT)
Historical Stock Chart
Von Okt 2024 bis Nov 2024
Median Technologies (EU:ALMDT)
Historical Stock Chart
Von Nov 2023 bis Nov 2024
